Registry Outcomes Support Sirolimus-Eluting Stent

Share this post

Compared with other frequently used newer-generation drug-eluting stents, the ultra-thin sirolimus-eluting device was associated with lower target lesion revascularization rates, new registry data suggest.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply